The present study demonstrated that exosomes derived from BMSCs were able to exert a significant effect on alleviating HF and reducing inflammation levels by increasing KLF4 in cardiomyocytes, providing a new direction and target point for the treatment of HF. The gene discussed is KLF4; the disease is hydrops fetalis.